Valuation Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
05:41:03 14/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,480.50 INR | -0.77% |
|
-3.64% | +34.95% |
| 15/08 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 12/08 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Company Valuation: Caplin Point Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 30,571 | 51,529 | 45,291 | 1,00,038 | 1,52,221 | 1,88,555 | - | - |
| Change | - | 68.55% | -12.11% | 120.88% | 52.16% | 23.87% | - | - |
| Enterprise Value (EV) | 30,571 | 51,529 | 45,291 | 1,00,038 | 1,52,221 | 1,88,555 | 1,88,555 | 1,88,555 |
| Change | - | 68.55% | -12.11% | 120.88% | 52.16% | 23.87% | 0% | 0% |
| P/E | 12.7x | 17.3x | 12.1x | 22x | 28.5x | 17.9x | 25.6x | 23.2x |
| PBR | 2.58x | 3.47x | 2.41x | 4.32x | 5.34x | 3.19x | 4.14x | 3.89x |
| PEG | - | 0.7x | 0.5x | 1x | 1.6x | 0.9x | 1.3x | 2.3x |
| Capitalization / Revenue | 2.88x | 4.06x | 3.09x | 5.91x | 7.86x | 5.23x | 7.54x | 6.72x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 8.86x | 7.54x | 6.72x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 25.4x | 21.4x | 19.2x |
| EV / EBIT | 0x | 0x | 0x | - | 0x | 24.2x | 20.2x | 17.5x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 49.6x | 31.5x | 34.8x |
| FCF Yield | 6.39% | 4.77% | 1.72% | 1.73% | 1.58% | 2.4% | 3.17% | 2.87% |
| Dividend per Share 2 | 3 | 2 | 2 | 2.5 | 3 | - | 4 | 4 |
| Rate of return | 0.74% | 0.29% | 0.34% | 0.19% | 0.15% | - | 0.16% | 0.16% |
| EPS 2 | 31.71 | 39.26 | 49.18 | 59.9 | 70.25 | 84.11 | 97 | 107 |
| Distribution rate | 9.46% | 5.09% | 4.07% | 4.17% | 4.27% | - | 4.12% | 3.74% |
| Net sales 1 | 10,613 | 12,694 | 14,667 | 16,941 | 19,375 | 21,872 | 25,008 | 28,053 |
| EBITDA 1 | 3,286 | 3,947 | 4,411 | 5,514 | 6,469 | 7,609 | 8,792 | 9,810 |
| EBIT 1 | 3,152 | 3,478 | 4,520 | - | 5,810 | 8,036 | 9,321 | 10,752 |
| Net income 1 | 2,423 | 2,998 | 3,763 | 4,571 | 5,363 | 6,412 | 7,369 | 8,124 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 404.15 | 679.90 | 596.70 | 1,317.30 | 2,002.60 | 2,480.60 | 2,480.60 | 2,480.60 |
| Nbr of stocks (in thousands) | 75,643 | 75,789 | 75,903 | 75,942 | 76,012 | 76,012 | - | - |
| Announcement Date | 06/05/21 | 12/05/22 | 27/05/23 | 16/05/24 | 15/05/25 | 14/05/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 35.61x | 6.69x | 23.16x | 0.89% | 4.84TCr | |
| 18.56x | 2.2x | 10x | 1.37% | 3.97TCr | |
| 28.23x | 3.44x | 17.81x | 0.9% | 1.23TCr | |
| 27.22x | 3.89x | 16.12x | 0.59% | 1.18TCr | |
| 18.63x | 3.31x | 11.51x | 3.87% | 906.17Cr | |
| 9.11x | 2.11x | 5.48x | 4.42% | 756.57Cr | |
| 15.83x | 2.06x | 6.7x | 3.22% | 717.59Cr | |
| 35.19x | 4.02x | 17.09x | 0.23% | 684.21Cr | |
| Average | 23.55x | 3.46x | 13.48x | 1.94% | 1.79TCr | |
| Weighted average by Cap. | 26.05x | 4.11x | 15.67x | 1.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CAPLIPOINT Stock
- CAPLIPOINT Stock
- Valuation Caplin Point Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
